Maxigen Biotech Inc. (1783.TW)

TWD 43.3

(-0.12%)

Eps Summary of Maxigen Biotech Inc.

Maxigen Biotech Inc.'s latest annual eps in 2023 was 1.86 TWD , up 18.47% from previous year.
Maxigen Biotech Inc.'s latest quarterly eps in 2024 Q2 was 0.67 TWD , up 106.25% from previous quarter.
Maxigen Biotech Inc. reported an annual eps of 1.57 TWD in 2022, up 49.52% from previous year.
Maxigen Biotech Inc. reported an annual eps of 1.05 TWD in 2021, up 32.91% from previous year.
Maxigen Biotech Inc. reported a quarterly eps of 0.67 TWD for 2024 Q2, up 106.25% from previous quarter.
Maxigen Biotech Inc. reported a quarterly eps of 0.47 TWD for 2023 Q3, down -32.86% from previous quarter.

Annual Eps Chart of Maxigen Biotech Inc. (2023 - 2009)

Historical Annual Eps of Maxigen Biotech Inc. (2023 - 2009)

Year	Eps	Eps Growth
2023	1.86 TWD	18.47%
2022	1.57 TWD	49.52%
2021	1.05 TWD	32.91%
2020	0.79 TWD	5.33%
2019	0.75 TWD	11.94%
2018	0.67 TWD	219.05%
2017	0.21 TWD	231.25%
2016	-0.16 TWD	80.25%
2015	-0.81 TWD	-224.0%
2014	-0.25 TWD	-786.81%
2013	0.04 TWD	-20.0%
2012	0.05 TWD	107.0%
2011	-0.65 TWD	-124.14%
2010	-0.29 TWD	-203.57%
2009	0.28 TWD	0.0%

Year	Eps	Eps Growth
2024 Q1	0.32 TWD	60.0%
2024 Q2	0.67 TWD	106.25%
2023 Q3	0.47 TWD	-32.86%
2023 Q1	0.50 TWD	2.04%
2023 Q2	0.70 TWD	40.0%
2023 FY	- TWD	18.47%
2023 Q4	0.20 TWD	-57.45%
2022 Q3	0.50 TWD	28.21%
2022 Q1	0.24 TWD	50.0%
2022 FY	- TWD	49.52%
2022 Q4	0.49 TWD	-2.0%
2022 Q2	0.39 TWD	62.5%
2021 Q2	0.28 TWD	0.0%
2021 Q4	0.16 TWD	-57.89%
2021 Q1	0.28 TWD	3.7%
2021 FY	- TWD	32.91%
2021 Q3	0.38 TWD	35.71%
2020 Q4	0.27 TWD	68.75%
2020 Q1	0.14 TWD	43.59%
2020 Q2	0.27 TWD	92.86%
2020 Q3	0.16 TWD	-40.74%
2020 FY	- TWD	5.33%
2019 Q4	0.10 TWD	-61.0%
2019 Q3	0.25 TWD	-28.57%
2019 FY	- TWD	11.94%
2019 Q1	0.09 TWD	-4.21%
2019 Q2	0.35 TWD	285.04%
2018 Q3	0.23 TWD	-25.81%
2018 Q2	0.31 TWD	181.82%
2018 Q4	0.09 TWD	-58.74%
2018 FY	- TWD	219.05%
2018 Q1	0.11 TWD	142.83%
2017 Q2	0.11 TWD	311.95%
2017 FY	- TWD	231.25%
2017 Q3	0.10 TWD	-9.09%
2017 Q1	-0.05 TWD	-209.73%
2017 Q4	0.05 TWD	-54.7%
2016 Q4	0.05 TWD	359.89%
2016 Q2	-0.05 TWD	67.5%
2016 Q1	-0.14 TWD	60.0%
2016 Q3	-0.02 TWD	60.0%
2016 FY	- TWD	80.25%
2015 Q1	-0.17 TWD	41.38%
2015 Q2	-0.20 TWD	-17.65%
2015 Q3	-0.07 TWD	63.25%
2015 Q4	-0.35 TWD	-376.19%
2015 FY	- TWD	-224.0%
2014 FY	- TWD	-786.81%
2014 Q2	-0.03 TWD	-175.0%
2014 Q1	0.04 TWD	31.41%
2014 Q4	-0.29 TWD	-1493.41%
2014 Q3	-0.02 TWD	33.33%
2013 Q1	-0.03 TWD	14.86%
2013 Q3	0.01 TWD	-66.67%
2013 Q4	0.03 TWD	204.4%
2013 FY	- TWD	-20.0%
2013 Q2	0.03 TWD	180.77%
2012 Q2	- TWD	0.0%
2012 Q4	-0.04 TWD	-196.27%
2012 Q3	-0.01 TWD	0.0%
2012 FY	- TWD	107.0%
2011 Q4	- TWD	0.0%
2011 FY	- TWD	-124.14%
2011 Q2	- TWD	0.0%
2010 FY	- TWD	-203.57%
2010 Q4	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Eps Comparison of Maxigen Biotech Inc.

Name	Eps	Eps Difference
Nang Kuang Pharmaceutical Co., Ltd.	1.96 TWD	5.102%
SciVision Biotech Inc.	2.66 TWD	30.075%
Bionime Corporation	0.10 TWD	-1760.0%
Pegavision Corporation	22.83 TWD	91.853%
Visco Vision Inc.	4.79 TWD	61.169%